Patel, AM and Moreland, LW
(2010)
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy.
Drug Design, Development and Therapy, 4.
263 - 278.
ISSN 1177-8881
Abstract
The dawn of the biologic era has been an exciting period for clinical research and patient care in rheumatoid arthritis (RA). Targeted biologic therapies have changed the outcome of this disease and made remission a realistic outcome for many patients. Tocilizumab (TCZ, Actemra®), is a humanized monoclonal antibody against the interleukin 6 receptor and has been approved in many countries for the treatment of moderate to severe RA. There have been a number of important clinical trials demonstrating the efficacy of TCZ in active rheumatoid arthritis. This review summarizes the data on efficacy, patient-reported outcomes, adverse events, and safety from some of these trials. Current trends in clinical practice will be discussed. It is difficult to place TCZ and many new medications in the algorithm of treatment at present. However, the next few years will hopefully reveal their role as we better define abnormal immune processes in individuals with RA.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID  |
---|
Patel, AM | | | | Moreland, LW | lwm5@pitt.edu | LWM5 | |
|
Date: |
1 December 2010 |
Date Type: |
Publication |
Access Restriction: |
No restriction; Release the ETD for access worldwide immediately. |
Journal or Publication Title: |
Drug Design, Development and Therapy |
Volume: |
4 |
Page Range: |
263 - 278 |
DOI or Unique Handle: |
10.2147/dddt.s14099 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Immunology |
Refereed: |
Yes |
ISSN: |
1177-8881 |
Article Type: |
Review |
Date Deposited: |
12 Dec 2012 20:44 |
Last Modified: |
22 Jun 2021 13:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/16856 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |